1974
DOI: 10.1073/pnas.71.11.4523
|View full text |Cite
|
Sign up to set email alerts
|

Glucose Inhibition of Epinephrine Stimulation of Hepatic Gluconeogenesis by Blockade of the α-Receptor Function

Abstract: For isolated rat hepatocytes, glucagon, The presence in liver of both phosphofructokinase (EC 2.7.1.11) and fructose diphosphatase (EC 3.1.3.11) provides for the possibility of a substrate cycle and the apparent futile hydrolysis of ATP. Until recently, it was considered that the reactions of glycolysis and gluconeogenesis were mutually exclusive and that minimal flux occurred through phosphofructokinase during periods of gluconeogenesis in liver. In recent studies in this laboratory significant rates of flux… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
14
0
2

Year Published

1976
1976
1982
1982

Publication Types

Select...
4
3
2

Relationship

1
8

Authors

Journals

citations
Cited by 72 publications
(18 citation statements)
references
References 20 publications
2
14
0
2
Order By: Relevance
“…Although this is the first demonstration of an acute increase in plasma norepinehprine (as opposed to epinephrine) during insulin-induced hypoglycemia (58), other investigators using 2-deoxyglucose-induced glucopenia in man have also emphasized the importance of the axonal release of norepinephrine for glucose homeostasis (59,60). Studies in vivo as well as in vitro have shown that both catecholamines activate glycogenolysis and increase the rate of gluconeogenesis from threecarbon intermediates such as alanine (2,3,12,61,62).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Although this is the first demonstration of an acute increase in plasma norepinehprine (as opposed to epinephrine) during insulin-induced hypoglycemia (58), other investigators using 2-deoxyglucose-induced glucopenia in man have also emphasized the importance of the axonal release of norepinephrine for glucose homeostasis (59,60). Studies in vivo as well as in vitro have shown that both catecholamines activate glycogenolysis and increase the rate of gluconeogenesis from threecarbon intermediates such as alanine (2,3,12,61,62).…”
Section: Discussionmentioning
confidence: 99%
“…Many of these hormones are thought to antagonize the hypoglycemic action of insulin, by modulating either glucose production or glucose utilization or both. Catecholamines (1)(2)(3), glucagon (4)(5)(6)(7)(8)(9), and cortisol (10,11) increase the rate of hepatic gluconeogenesis from three-carbon precursors, such as lactate and alanine. Catecholamines and glucagon also accelerate hepatic glycogenolysis (12,13).…”
Section: Introductionmentioning
confidence: 99%
“…In contrast, stimulation of hepatic gluconeogenesis by a-adrenergic agonists is accompanied by changes in membrane permeability and resultant alterations in cellular contents of several ionic species (3,4) but proceeds, under some circumstances at least, without alterations in cyclic nucleotide levels (5)(6)(7). Because of its central role in regulation of cellular function, considerable attention has focused upon the possible involvement of changes in cellular Ca2+ in the mechanism of action of the a-adrenergic hormones.…”
mentioning
confidence: 99%
“…Hypoglycaemia increases the circulating levels of several hormones, some of which, CA (Kneer, Bosch, Clark & Lardy, 1974), glucagon (Clark, Kneer, Bosch & Lardy, 1974) and cortisol (Exton, 1972), directly Figure 4 Effect of anti-angiotensin I antibodies on catecholamine release from cat adrenal medulla in response to hypoglycaemia: (-) control cats injected wiith insulin (10 u/kg; n = 9); (0) experimental group, cats administered insulin (10 u/kg; n = 4) and angiotensin I antibodies; the period of angiotensin I antibodies (Ab) infusion (0.1 ml kg-' min-') is indicated; I I Indicates time of insulin injection. *P < 0.05; **P < 0.02; ***P < 0.001.…”
Section: Discussionmentioning
confidence: 99%